Prof. Andrea Rockall

The Mint Medical team has worked tirelessly with Imperial College London to develop and support an entire bespoke software platform to host the NIHR funded MROC study, from patient registration to the end of study.  Co-ordinating CT and multiparametric MRI images, blinded double reads, treatment plans, surgical and histopathology findings and outcomes on the MROC platform has transformed the way we can deliver image-based clinical trials and bio-banking of study data.

Related Resources

Related Resources

Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.

Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?

RSNA 2025

11/30 to 12/03/2025 Chicago, Illinois

Annual Meeting of the Radiological Society of North America

Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.

Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion

Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…